Literature DB >> 11827797

Differential regulation of MMP-1/9 and TIMP-1 secretion in human monocytic cells in response to Mycobacterium tuberculosis.

J S Friedland1, T C Shaw, N M Price, J-M Dayer.   

Abstract

In tuberculosis, matrix metalloproteinase (MMP) secretion is involved in leukocyte migration to sites of infection but in excess may contribute to tissue destruction. We demonstrate that human monocytic THP-1 cells and primary monocytes secrete MMP-1 (52 kD collagenase) when phagocytosing live, virulent M. tuberculosis but not inert latex. The magnitude of MMP-1 secretion was approximately 10-fold less when compared to MMP-9 (92 kD gelatinase) secretion. MMP-1 secretion was also relatively delayed (detected at 24 h vs. 4 h). M. tuberculosis, zymosan or latex stimulate similar TIMP-1 secretion within 8 h and increasing over 24 h. MMP-1/9 secretion was decreased by inhibitors of protein kinase (PK) C, PKA or tyrosine kinases (PTK) in a concentration-dependent manner. In contrast, TIMP-1 secretion was not affected by PKC or PTK blockade and only somewhat reduced by high level PKA inhibition. In summary, M. tuberculosis-infected monocytes secrete MMP-1 at lower concentrations than MMP-9 and such MMP secretion is regulated by multiple upstream signalling pathways which do not control TIMP-1 secretion. Divergent effects of i on MMP and TIMP secretion from monocytes may be important in influencing matrix degradation in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11827797     DOI: 10.1016/s0945-053x(01)00175-5

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  16 in total

Review 1.  Host-directed therapeutics for tuberculosis: can we harness the host?

Authors:  Thomas R Hawn; Alastair I Matheson; Stephen N Maley; Omar Vandal
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

2.  TLR4 protein contributes to cigarette smoke-induced matrix metalloproteinase-1 (MMP-1) expression in chronic obstructive pulmonary disease.

Authors:  Patrick Geraghty; Abdoulaye J Dabo; Jeanine D'Armiento
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

3.  Mycobacterial lipomannan induces matrix metalloproteinase-9 expression in human macrophagic cells through a Toll-like receptor 1 (TLR1)/TLR2- and CD14-dependent mechanism.

Authors:  Elisabeth Elass; Laëtitia Aubry; Maryse Masson; Agnès Denys; Yann Guérardel; Emmanuel Maes; Dominique Legrand; Joël Mazurier; Laurent Kremer
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 4.  Biomarkers for Detecting Resilience against Mycobacterial Disease in Animals.

Authors:  Kathryn Wright; Karren Plain; Auriol Purdie; Bernadette M Saunders; Kumudika de Silva
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

5.  Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.

Authors:  Catherine W M Ong; Paul T Elkington; Jon S Friedland
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

6.  Host gene-encoded severe lung TB: from genes to the potential pathways.

Authors:  M Ganachari; H Guio; N Zhao; P O Flores-Villanueva
Journal:  Genes Immun       Date:  2012-09-20       Impact factor: 2.676

7.  Mycobacterium tuberculosis-infected human monocytes down-regulate microglial MMP-2 secretion in CNS tuberculosis via TNFα, NFκB, p38 and caspase 8 dependent pathways.

Authors:  Justin A Green; Shruti Dholakia; Karolina Janczar; Catherine Wm Ong; Rachel Moores; Julie Fry; Paul T Elkington; Federico Roncaroli; Jon S Friedland
Journal:  J Neuroinflammation       Date:  2011-05-11       Impact factor: 8.322

8.  ACE/ACE2 ratio and MMP-9 activity as potential biomarkers in tuberculous pleural effusions.

Authors:  Wen-Yeh Hsieh; Tang-Ching Kuan; Kun-Shan Cheng; Yan-Chiou Liao; Mu-Yuan Chen; Pei-Heng Lin; Yuan-Chang Hsu; Chen-Yi Huang; Wei-Hua Hsu; Sheng-Yao Yu; Chih-Sheng Lin
Journal:  Int J Biol Sci       Date:  2012-10-17       Impact factor: 6.580

9.  Matrix metalloproteinase-1 polymorphism (-1607G) and disease severity in non-cystic fibrosis bronchiectasis in Taiwan.

Authors:  Meng-Heng Hsieh; Pai-Chien Chou; Chun-Liang Chou; Shu-Chuan Ho; Wen-Ching Joa; Li-Fei Chen; Te-Fang Sheng; Horng-Chyuan Lin; Tsai-Yu Wang; Po-Jui Chang; Chun-Hua Wang; Han-Pin Kuo
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

10.  Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment.

Authors:  Mary A De Groote; Payam Nahid; Leah Jarlsberg; John L Johnson; Marc Weiner; Grace Muzanyi; Nebojsa Janjic; David G Sterling; Urs A Ochsner
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.